Clinical Trials in Austin

Showing 6741-6760 of 15,205 trials

HMPL-523 CYP3A/P-gp Inhibitor and CYP Inducer Study

NCT05720767

A Phase 1, Open-label, 2-Part, 2-Period Fixed-Sequence Crossover Study to Assess the Effect of Itraconazole, a CYP3A and P-glycoprotein Inhibitor, and the Effect of Rifampin, a CYP Enzyme Inducer, on the Pharmacokinetics of HMPL-523 in Healthy Volunteers

Relapsed or Refractory Lymphoma

Hutchmed28 participantsStarted Nov 2022

Austin, Texas, United States

COMPLETEDPhase 2< 1 mile

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

NCT01430442

The primary purpose of this study is to evaluate the efficacy of rimegepant (BMS-927711) compared with placebo in the acute treatment of migraine as measured by Pain Freedom (headache pain intensity level reported as "no pain") at 2 hours post dose using a four point numeric rating scale (no pain, mild pain, moderate pain, severe pain) while identifying an optimal dose to support the Phase 3 clinical trials.

MigraineAcute Treatment of Migraine

Pfizer1,026 participantsStarted Oct 2011

Scottsdale, Arizona, United States • Tempe, Arizona, United States • San Francisco, California, United States +38 more locations

HMPL-523 CYP3A/P-gp Inhibitor and CYP Inducer Study

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Find Trials by Condition in Austin

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

HMPL-523 Food Effect and Proton Pump Inhibitor Study

Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee

Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Expanded Access Protocol Using 131I-MIBG

An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)

Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)

Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)

A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis

Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia

A Study of ADXS-NEO Expressing Personalized Tumor Antigens

L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects

Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart Failure

Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition

VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers